Security key
M8769Q102
Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share
CUSIP: M8769Q102
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Ordinary Shares, par value NIS 0.10 per share
- Total 13F shares
- 44,294
- Total 13F value
- $742,367
- Share change
- +44,294
- SEC-reported price per share
- $16.76
- Number of holders
- 1
- Value change
- +$742,367
- Number of buys
- 1
- Shares outstanding
- 1,148,024,683
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
1
Top holders
1
M8769Q102 full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
TEVA PHARMACEUTICAL INDUSTRIES LTD SEC filings
TEVA PHARMACEUTICAL INDUSTRIES LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP M8769Q102
Recent filing periods:
Ownership snapshot
Top reported holders of M8769Q102 - Teva Pharmaceutical Industries Ltd - Ordinary Shares, par value NIS 0.10 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2025
13F
Lead comparable stake: 7.2%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 7.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
7.2%
BlackRock, Inc.
4.5%
Ion Asset Management Ltd.
3.4%
Clal Insurance Enterprises Holdin...
3.3%
MENORA MIVTACHIM HOLDINGS LTD.
2.5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
7.2%
|
$1,271,744,786
82,742,016 shares
|
— | 31 Mar 2025 |
| BlackRock, Inc. |
13F
Company
|
4.5%
|
$802,681,237
52,223,893 shares
|
— | 31 Mar 2025 |
| Ion Asset Management Ltd. |
13F
Company
|
3.4%
|
$599,944,895
39,033,500 shares
|
— | 31 Mar 2025 |
| Clal Insurance Enterprises Holdings Ltd |
13F
Company
|
3.3%
|
$578,331,000
37,794,068 shares
|
— | 31 Mar 2025 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
Company
|
2.5%
|
$448,639,787
29,189,316 shares
|
— | 31 Mar 2025 |
| Lingotto Investment Management LLP |
13F
Company
|
2.4%
|
$428,115,104
27,853,943 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
44,294
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q2 2025 holders
1
Holder diff
0
| Investor | Q3 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend